Molecular Panel Testing

Molecular Panel Testing is a molecular screening methodology that involves the simultaneous analysis of multiple genes, mutations, or biomarkers within a single assay to identify specific genetic alterations associated with disease diagnosis, prognosis, or therapeutic response.

Publications

8.9K

Citations

910

Authors

403

Institutions

Publications per year

2017–2026

Variants

Molecular Panel Screening

Parents

Molecular Screening

Publications

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Neal I. Lindeman, Philip T. Cagle, Mary Beth Beasley et al. · Journal of Thoracic Oncology · 2013 · 1.3K citations · Full text

Medicine, Molecular Medicine, Oncology +17

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner et al. · Archives of Pathology & Laboratory Medicine · 2018 · 931 citations · Full text

Medicine, Oncology, Pathology +17

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors

Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner et al. · Journal of Thoracic Oncology · 2018 · 633 citations · Full text

Medicine, Molecular Medicine, Oncology +16

PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels

Antonio Rueda Martin, Eleanor Williams, Rebecca E. Foulger et al. · Nature Genetics · 2019 · 594 citations

Life Sciences, Genetics, Molecular Genetics +8

Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update

Gregory P. Kalemkerian, Navneet Narula, Erin B. Kennedy et al. · Journal of Clinical Oncology · 2018 · 488 citations

Medicine, Oncology, Pathology +17

1–5 of 91

Authors

910

ML
Marc Ladanyi
Memorial Sloan Kettering Cancer Center, United States
7 publications · 4.1K citations
7
h-index
ET
Erik Thunnissen
Amsterdam UMC Location Vrije Universiteit Amsterdam, Netherlands
6 publications · 4.1K citations
6
h-index
NI
Neal I. Lindeman
Brigham and Women's Hospital, United States
6 publications · 4.1K citations
6
h-index
PT
Philip T. Cagle
Baylor College of Medicine, United States
6 publications · 4.1K citations
6
h-index
MB
Mary Beth Beasley
Icahn School of Medicine at Mount Sinai, United States
6 publications · 4.1K citations
6
h-index

1–5 of 910

Institutions

403

1–8 of 403

Venues

Journal of Clinical Oncology
5 publications · 840 citations
5
h-index
PLoS ONE
4 publications · 113 citations
4
h-index
Clinical Genetics
4 publications · 194 citations
4
h-index
Archives of Pathology & Laboratory Medicine
4 publications · 1.4K citations
4
h-index
Journal of Molecular Diagnostics
JMD · 3 publications · 825 citations
3
h-index

1–5